Table 5.
Study activity | 2021 | 2022 | 2023 | 2024 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | |
Baseline cohort enrollmenta | X | |||||||||||||
Baseline cohorta | X | X | ||||||||||||
Ethnographic data collectiona | X | X | X | X | ||||||||||
Randomization of clusters to ATSB or control | X | |||||||||||||
ATSB deployment or replacement | X | X | X | X | ||||||||||
ATSB monitoring | X | X | X | X | X | X | X | X | ||||||
Adverse event monitoring | X | X | X | X | X | X | X | X | X | |||||
Cohort enrollmentsa | X | X | X | X | ||||||||||
Cohort monthly follow-upsa | X | X | X | X | X | X | X | X | ||||||
Household surveysa | X | X | X | X | X | X | X | X | ||||||
Passive surveillance | X | X | X | X | X | X | X | X | X | |||||
Cost data collection | X | X | X | X | X | X | X | X | X | |||||
Entomological monitoring | X | X | X | X | X | X | ||||||||
Data analyses | X | X | X | |||||||||||
Data dissemination | X | X |
aInformed consent and assent obtained